Bluebird bio is a biotechnology business intended to help the communities and patients it serves. It is a startup dedicated to recoding science in order to enable persons suffering from serious genetic disorders and cancer rewrite their tales. The first product, ZYNTEGLOTM (autologous CD34+ cells encoding the A-T87Q-globin gene), has received EU Conditional Marketing Authorization. Bluebird Bio has signed an exclusive license deal with Inhibrx to research, develop, and commercialize chimeric antigen receptor (CAR) T cell treatments for several cancer targets in a view to use Inhibrx's patented single domain antibody (sdAb) platform. European Medicines Agency has also given permission to experimental therapy. They are hiring associate director, biostatistics and senior clinical research associate.
What departments bluebird bio employees work at?
You comment as